Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial].

Pastural M, Barrou B, Golmard JL, Gorichon-Radideau E, Manighetti J, Ourahma S, Benalia H, Mouquet C, Chatelain C, Bitker MO.

Prog Urol. 1999 Feb;9(1):19-25. Review. French.

PMID:
10212949
3.

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.

[No authors listed]

Transplantation. 1998 Jan 27;65(2):235-41. Erratum in: Transplantation 1998 Apr 15;65(7):followi.

PMID:
9458021
4.

A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.

Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.

Transplantation. 1998 Dec 27;66(12):1751-9.

PMID:
9884272
6.

Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.

Wüthrich RP, Weinreich T, Ambühl PM, Schwarzkopf AK, Candinas D, Binswanger U.

Nephrol Dial Transplant. 1999 Feb;14(2):394-9.

7.

Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation.

Zuckermann A, Klepetko W, Birsan T, Taghavi S, Artemiou O, Wisser W, Dekan G, Wolner E.

J Heart Lung Transplant. 1999 May;18(5):432-40.

PMID:
10363687
8.

Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation.

Wüthrich RP, Cicvara S, Ambühl PM, Binswanger U.

Nephrol Dial Transplant. 2000 Aug;15(8):1228-31.

9.

Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.

Kahu J, Lõhmus A, Ilmoja M, Kirsimägi U, Timberg G, Peetsalu A.

Medicina (Kaunas). 2007;43(12):953-8.

10.

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C.

Transplantation. 1997 Jan 15;63(1):39-47. Erratum in: Transplantation 1997 Feb 27;63(4):618.

PMID:
9000658
11.

Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.

Schweitzer EJ, Yoon S, Fink J, Wiland A, Anderson L, Kuo PC, Lim JW, Johnson LB, Farney AC, Weir MR, Bartlett ST.

Transplantation. 1998 Jan 27;65(2):242-8.

PMID:
9458022
12.

Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.

Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.

Ann Transplant. 2000;5(1):43-6.

PMID:
10850611
15.

Mycophenolate mofetil in pancreas transplantation.

Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.

Transplantation. 1998 Aug 15;66(3):318-23.

PMID:
9721799
16.
17.
18.
19.

Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.

Clayton PA, McDonald SP, Chapman JR, Chadban SJ.

Transplantation. 2012 Jul 27;94(2):152-8. doi: 10.1097/TP.0b013e31825475a3.

PMID:
22728292
20.

Long-term graft outcome with mycophenolate mofetil and azathioprine: A paired kidney analysis.

Shah S, Collett D, Johnson R, Thuraisingham RC, Raftery MJ, Rudge CJ, Yaqoob MM.

Transplantation. 2006 Dec 27;82(12):1634-9.

PMID:
17198250
Items per page

Supplemental Content

Support Center